Neal Walker, President and CEO at Aclaris Therapeutics, Inc. (ACRS), bought 10,000 shares at $16.75 ($168K) on 2018-04-05, disclosed to the SEC on 2018-04-09.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| ACRS | SELL | 2023-01-04 | $960K | — | Filing → |
| ACRS | SELL | 2022-04-25 | $1.1M | — | Filing → |
| ACRS | SELL | 2022-03-14 | $1.8M | — | Filing → |